Coated Abrasives Market is Expected to Grow at a CAGR of 7.4% from 2016 to 2022

Coated Abrasives Market – by grain type (Aluminum oxide, Silicon carbide), by backing materials, by end user industry and by Region – Forecast till 2022

Major Key Players include Saint-Gobain S.A.,DuPont,Robert Bosch GmbH,3Mm,Cabot Microelectronics Corp,Hermes Schleifmittel GmbH,Henkel AG & Co. KGaA”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, March 29, 2017 /EINPresswire.com/ — Market Highlights
Coated abrasives are used to grind, scour, clean or remove solid materials by rubbing action or by impact using equipment’s. Coated Abrasive market is expected to grow at rapid pace owing to its growing applications such as auto OEMs, fabrication, furniture, flooring etc.
Coated Abrasives are manufactured from synthetic or natural grain minerals such as aluminum oxide, silicon carbide, zirconia alumina and ceramic. These grain minerals are supported by backing materials such as paper, cloth, fiber, polyester film, others. These materials are then transformed into jumbo rolls which are then cut down into shapes such as discs, sheets, belts and rolls for smoothening, polishing and surface treatment application. Coated Abrasives market is set for intensifying growth in automotive, fabrication, jewelry applications and is expected to grow at CAGR of ~7.4% between 2016-2022

Rise in demand for coated abrasives in welding, foundry, automotive industry is anticipated to propel the demand for coated abrasives market in coming years. The use of coated abrasive in order to improve the surface finish along with high productivity is driving the coated abrasive market growth. Owing to superior properties, industrial abrasive users are considering coated abrasive as a better option over conventional abrasives.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2413

According to grain type, the coated abrasives market is segmented as aluminum oxide, silicon carbide, zirconia alumina, ceramic. Aluminum oxide accounted for major share owing to its properties such as high toughness and durability. Due to its properties, it is used in various applications such as metal fabrication and woodworking. The increased in demand for aluminum oxide in grinding nonmetallic material such as wood and plastic and non-ferrous material like aluminum, zinc etc. has boosted the market demand of coated abrasive over the forecasted period. According to backing materials, coated abrasives are segmented into paper, cloth, fiber, polyester film, others. Fiber backing material based coated abrasive account for major shares and dominate the market growth in coming years. Rising popularity of coated abrasives and development of recent nonwoven fabric abrasives is anticipated to drive the coated abrasive market growth. The recent introduction of flexible belts, seeded gel abrasives, polyester backed abrasives by various manufacturers has opened opportunities in various regions. Fluctuation in raw materials, underdeveloped testing facilities and quality equipment’s is expected to hinder the market growth over the forecasted period. High energy consumption and labor strikes is expected to have negative impact on coated abrasives.

Competitive analysis:
• Saint-Gobain S.A. (Europe),
• DuPont (Germany),
• Robert Bosch GmbH (Germany),
• 3Mm (U.S),
• Cabot Microelectronics Corp (U.S),
• Hermes Schleifmittel GmbH (Germany),
• Henkel AG & Co. KGaA (Germany),
• Asahi Diamond Industrial Co. Ltd. (Japan),
• VSM Abrasive AG (Germany),
• Carborundum Universal Ltd (India)
• others

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Coated Abrasives Market Research Report- Forecast to 2022

Segmentation:
The global Coated Abrasives market is majorly segmented on the basis of grain type, backing materials and end user industry.
On Basis of grain type, coated abrasives market is segmented into aluminum oxide, silicon carbide, zirconia alumina, ceramic.
On Basis of backing material, coated abrasives are segmented into paper, cloth, fiber, polyester film, others.
On Basis of end user industry of Coated Abrasives, the market is segmented into transportation, metal fabrication, consumer goods, automotive, others.

Table of Content

1 Executive Summary
2 Scope of The Report
2.1 Market Definition
2.2 Scope of The Study
2.2.1 Research Objectives
2.2.2 Assumptions & Limitations
2.3 Markets Structure
3 Market Research Methodology
3.1 Research Process
3.2 Secondary Research
3.3 Primary Research
3.4 Forecast Model
4 Market Landscape
4.1 Five Forces Analysis
4.1.1 Threat of New Entrants
4.1.2 Bargaining power of buyers
4.1.3 Threat of substitutes
4.1.4 Segment rivalry
4.2 Value Chain/Supply Chain of Global Coated Abrasives Market
5 Industry Overview of Global Coated Abrasives Market
5.1 Introduction
5.2 Growth Drivers
5.3 Impact analysis
5.4 Market Challenges
5.5 Impact analysis
6 Market Trends
Continue………..

Related Report
Global Image Sensor Market Information, by Application (Mobile Phones, Tablets, PC Camera, DSC, Automotive, Medical, Security), by Technology (CMOS and CCD), by Operating Spectrum (Visible and Invisible), by Array Type (Linear and Area)-Forecast 2016-2021.know more about this report @ https://www.marketresearchfuture.com/reports/global-image-sensor-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Global Thermoform Packaging Market is predicted to grow at approximately 7% by 2022

Thermoform Packaging Market is predicted to grow at approximately 7% & Cross to USD 32 Billion Mark by 2022

Key Players : Bemis Company, Inc., Sonoco Products Company, E.I. du Pont de Nemours and Company, Amcor Limited, DS Smith Plc., WestRock Company, Display Pack Inc, Tray Pack Corporation”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, March 29, 2017 /EINPresswire.com/ — Market Highlights
The increasing demand from food & beverage and pharmaceuticals industries globally drives the market. The large consumer base, increasing manufacturing activities, cost-effective, environment friendly and increase in spending by consumers for packaged food. PET leads the market, majorly due to replacing polystyrene resin. Europe is the largest market. The global thermoform packaging market size was valued at around USD 32 Billion in 2015 and is expected to grow at CAGR of 7% by 2022.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1851

The Key Players of Global Thermoform Packaging Market
• Bemis Company, Inc.
• Sonoco Products Company
• E.I. du Pont de Nemours and Company
• Amcor Limited
• DS Smith Plc.
• WestRock Company
• Display Pack Inc
• Tray Pack Corporation
• Lacerta Group Inc
• Sealed Air

Market Research Analysis
The market is highly application based. The factors contributing to the growth of the global thermoform packaging market is the increasing demand for convenient packaging, growth in food & beverage industry and cost-effective. The market is expected to have higher growth rate as compared to the previous years. Europe is the largest region for the thermoform packaging market, followed by Asia-Pacific and North-America. The main reason for the growth in the region includes the rapid growth of industries such as food & beverage and pharmaceuticals in Germany.

Scope of the Report
This study provides an overview of the global thermoform packaging market, tracking two market segments across four geographic regions. The report studies key players, providing a five-year annual trend analysis that highlights market size, volume and share for North America, Europe, Asia Pacific, and Rest of the World. The report also provides a forecast, focusing on the market opportunities for the next five years for each region. The scope of the study segments the global thermoform packaging market as material, type and application.

By Material
1. Plastic
a. PET
b. PP
c. PVC
d. Others
2. Paper
3. Aluminium
4. Others
By Type
1. Blister Packaging
2. Skin Packaging
3. Clamshell Packaging
4. Others
By Application
1. Food & beverage
2. Pharmaceutical
3. Electronics
4. Personal care
5. Others

Browse full TP Market @ https://www.marketresearchfuture.com/reports/thermoform-packaging-market

Table of Content
1 Executive Summary
2 Scope of The Report
3 Market Research Methodology
4 Market Landscape
5 Industry Overview of Global Thermoform Packaging Market
6 Market Trends
7. Global Thermoform Packaging Market by Type
8. Global Thermoform Packaging Market by Material
9. Global Thermoform Packaging Market by Application
10. Global Thermoform Packaging Market by Region
11. Company Profiles
11.1 Bemis Company, Inc.
11.2 Sonoco Products Company
11.3 E.I. du Pont de Nemours and Company
11.4 Amcor Limited
Continued….

Taste the market data and market information presented through more than 85 market data tables and figures spread in 130 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Thermoform Packaging Market Information from 2014 to 2022"

LIST OF TABLES
Table 1 World Population by Major Regions (2015 To 2030) (Million)
Table 2 Global Thermoform Packaging Market: By Region, 2014-2022 (Usd Million)
Table 3 Global Thermoform Packaging Market: By Region, 2014-2022 (Kt)
Table 4 North America Thermoform Packaging Market: By Country, 2022 (Usd Million)
Table 5 Europe Thermoform Packaging Market: By Country, 2014-2022 (Usd Million)
Table 6 Asia-Pacific Thermoform Packaging Market: By Country, 2022 (Usd Million)
Continued….

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Global Operational Intelligence Market to Reach $6 billion with 12.56% CAGR Forecast to 2022

Operational Intelligence Global Market – By Deployment (On premises, On Demand), Industry, Countries and Forecast to 2022

PUNE, INDIA, March 29, 2017 /EINPresswire.com/ — The market for Operational intelligence (OI) is estimated to cross $6 billion by end of 2020, growing at a CAGR of 12.56% over the six year forecasted period. For many years, business intelligence existed to be the key to the enterprise computing however, operational intelligence has emerged as one of the hot buttons podium in the recent years for driving business optimization.
Request a sample report @ https://www.wiseguyreports.com/sample-request/474337-global-operational-intelligence-market-by-deployment-forecasts-and-trends-2015-2020
Operational intelligence is one of the key levers for uplifting operational efficiency. It equips organizations with actionable insights into their key drivers, across the entire value chain. It places complete information at one's fingertips, enabling one to make smarter decisions in time to maximize impact. By correlating a wide variety of events and data from both streaming feeds and historical data silos, OI helps organizations gain real-time visibility of information, in context, through advanced dashboards, real-time insight into business performance, health and status so that immediate action based on business policies, processes and activities, as they are executed.
Operational Intelligence applies the benefits of real-time analytics, alerts, and actions to a broad spectrum of user cases across and beyond the enterprise. The collection, sharing, analysis and application of Operational Intelligence via web-based technology gives decision makers at all levels in a commercial organization an exceptional means to maximize the use of their resources. OI tells them precisely what is going on, in the precise domain or geographical location of their operation that concerns them.
Operational Intelligence is an evolutionary and technological leap beyond Business Intelligence and Management Information systems that presented retrospective, static and at best generic intelligence about an organizations performance. These unique advantages of OI over conventional tools will drive the market ahead in the coming years as companies that enable their management to respond in a timely manner to operational variances and market volatility are better placed to minimize the adverse impacts caused by uncertain operational procedures and disturbances in the market. It helps companies by serving as a platform to improve their situation awareness and ability to sense and respond quickly to changing business conditions.
In the recent years, organizations of all formats employees are anticipated to attain measurable performance objectives that aligns with the customer demands, strategic business initiatives and regulatory compliance obligations. By utilizing both real-time and historical data, OI provides situational awareness, predictive insight and actionable intelligence in the right context to the right person at the right time thus accelerating the growth of the business.
Growth in the adoption of Business Intelligence Solutions, focus on cost reduction and improving process efficiency are some of the driver fuelling the growth of the operational intelligence market. However, data integrity issues related to multiple data sources and need for manual adjustments could cause some hindrance in the demand for this particular market.
The global operational intelligence market has been broadly segmented on the basis of deployment model (On-Premise and On-Demand) and end user industry (telecommunication, energy and power, financial services, retail, healthcare, travel and transport/logistics, government and others).
The market has also been geographically segmented into North America, Asia Pacific, Europe and Rest of the World. In 2014, North America held the major share in the operational intelligence market globally and is expected to dominate the market throughout the forecast period owing to high adoption of cloud Business Intelligence and data analytics, contributing majorly towards the market growth.
Some of the companies mentioned in the report are Flexeye, Vitria, GE, Splunk, Starview Inc., SAP, HP, OpenText Corp., IBENOX Pty Ltd and Invensys.
Key Deliverables in the Study
• Market analysis for the global operational intelligence market with region specific assessments and competition analysis on global and regional scales
• Market definition along with the identification of key drivers and restraints
• Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
• Extensively researched competitive landscape section with profiles of major companies along with their market shares
• Identification and analysis of the macro and micro factors that affect the operational intelligence market on both global and regional scales
• A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
• A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
• Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Complete report details @ https://www.wiseguyreports.com/reports/474337-global-operational-intelligence-market-by-deployment-forecasts-and-trends-2015-2020
Key points in table of content
1. Introduction
1.1.1 Research Methodology
1.1.2 Report Description
1.1.3 Key Findings of the Study
2. Executive Summary
3. Market Overview
3.1 Overview
3.2 Industry Value Chain Analysis
3.3 Industry Attractiveness – Porter's 5 Force Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Consumers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitute Products or Services
3.3.5 Competitive Rivalry among Existing Competitors
3.4 Industry Policies
4. Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growth in adoption of BI solutions
4.2.2 Focus on cost reduction and improving process efficiency
4.3 Restraints
4.3.1 Data integrity issues related to multiple data sources and Need for manual adjustments
5. Technology Overview
5.1 Technology Snapshot
5.2 Applications of Operation Intelligence Platforms
6. Operational Intelligence Market by Deployment Model
6.1 On-Premise
6.1.1 Market Share and Analysis
6.1.2 Analyte View
6.2 On-Demand
6.2.1 Market Share and Analysis
6.2.2 Analyte View

Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=474337

Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Carcinoembryonic Antigen (CEA) Market 2016: Company Profiles, Market Segments, Landscape, Demand and Forecast – 2027



Market Research Future

Carcinoembryonic Antigen (CEA) Market Analysis and Forecast by Application (Prostate Cancer, Lung Cancer, Breast Cancer, Thyroid Cancer, Liver Cancer) – 2027

Major Key Players are Roche Diagnostics, Quest Diagnostics, Correlogic Systems, Inc., GenWay Biotech Inc.”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, March 29, 2017 /EINPresswire.com/ — Market Overviews:

CEA stands for Carcinoembryonic antigen. CEA is a form of glycoprotein molecule that is generated by cells of the gastrointestinal tract during embryonic development. It is produced in very small quantity after birth. The level of CEA in the bloodstream is thus relatively low unless certain diseases – including certain forms of cancer – are present. Carcinoembryonic antigen (CEA) portrays an arrangement of highly related glycoproteins involved in cell attachment. CEA is normally present just at low levels in the blood of healthy adults. In any case, if the serum levels are brought up in some type of cancer, which implies that it, can be used as a tumor maker in clinical tests. Serum levels can likewise be raised in overwhelming smokers.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/772

Regional Analysis:

Europe

Europe is the second largest market for Carcinoembryonic Antigen (CEA). This is also because the high growth rate of cancer in Europe. Most cancers are related to lifestyle, behavioral or environmental exposures.

North America

Carcinoembryonic Antigen (CEA) Market for North America is one of the biggest markets in the globe the main reason behind this is the Cancer rate in the North American countries. Cancer usually develops in older people 86% of all cancers in the United States are diagnosed in people 50 years of age or older.

Key Players:

• Roche Diagnostics
• Quest Diagnostics
• Correlogic Systems, Inc.,
• GenWay Biotech Inc.

Market Growth Driver:

With the diagnosis of different types of cancers in the globe, Carcinoembryonic Antigen (CEA) Market test helps the doctor to diagnose and find out the type of cancer present in the patient’s body. With this unique quality CEA tests demand and market will be in huge demand and this market will be highly lucrative.

The common reasons other than cancer for the growth of Carcinoembryonic antigen CEA are

• Cirrhosis of the liver
• Inflammatory bowel disease
• Heavy smoking
• Infection

Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 126 numbers of pages of the project report “Carcinoembryonic Antigen (CEA) Market- Forecast to 2027"

Carcinoembryonic Antigen (CEA) Test Application

A CEA test is most useful if you’ve been diagnosed with a type of cancer, which is known to produce CEA. Not all types of cancers produce CEA. Increased levels of CEA may be found in the following cancers
• Breast cancer
• Lung cancer
• Prostate cancer
• Liver cancer
• Colorectal cancer

Access Report Details @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Global Viral Clearance Market 2017 Share, Trend, Segmentation and Forecast to 2022

Global Viral Clearance market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer

PUNE, MAHARASTRA, INDIA, March 29, 2017 /EINPresswire.com/ — Summary

Wiseguyreports.Com Adds “Viral Clearance – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 To 2022”

Global Viral Clearance market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Avance Biosciences Inc.
BSL BIOSERVICE
Clean Cells
Charles River Laboratories International
Lonza Group
Merck & Co.
Sigma-Aldrich Corporation
SGS S.A.
Texcell, Inc.
WuXi AppTec

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/1079948-global-viral-clearance-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Viral Clearance in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Viral Detection Method
Viral Removal Method
Viral Inactivation Method

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Viral Clearance for each application, including
Stem Cell
Blood
Tissue
Cell & Gene Therapy
Other

Complete report details @ https://www.wiseguyreports.com/reports/1079948-global-viral-clearance-market-research-report-2017

Table of Contents

Global Viral Clearance Market Research Report 2017
1 Viral Clearance Market Overview
1.1 Product Overview and Scope of Viral Clearance
1.2 Viral Clearance Segment by Type (Product Category)
1.2.1 Global Viral Clearance Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Viral Clearance Production Market Share by Type (Product Category) in 2016
1.2.3 Viral Detection Method
1.2.4 Viral Removal Method
1.2.5 Viral Inactivation Method
1.3 Global Viral Clearance Segment by Application
1.3.1 Viral Clearance Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Stem Cell
1.3.3 Blood
1.3.4 Tissue
1.3.5 Cell & Gene Therapy
1.3.6 Other
1.4 Global Viral Clearance Market by Region (2012-2022)
1.4.1 Global Viral Clearance Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Viral Clearance (2012-2022)
1.5.1 Global Viral Clearance Revenue Status and Outlook (2012-2022)
1.5.2 Global Viral Clearance Capacity, Production Status and Outlook (2012-2022)

……

7 Global Viral Clearance Manufacturers Profiles/Analysis
7.1 Avance Biosciences Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Viral Clearance Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Avance Biosciences Inc. Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 BSL BIOSERVICE
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Viral Clearance Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 BSL BIOSERVICE Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Clean Cells
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Viral Clearance Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Clean Cells Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Charles River Laboratories International
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Viral Clearance Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Charles River Laboratories International Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Lonza Group
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Viral Clearance Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Lonza Group Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Merck & Co.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Viral Clearance Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Merck & Co. Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Sigma-Aldrich Corporation
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Viral Clearance Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Sigma-Aldrich Corporation Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 SGS S.A.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Viral Clearance Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 SGS S.A. Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Texcell, Inc.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Viral Clearance Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Texcell, Inc. Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 WuXi AppTec
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Viral Clearance Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 WuXi AppTec Viral Clearance Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1079948

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Lake Grove, New York Dentist Selected to the "America's Best Dentists" 2017 Directory

Dr. Robert Branca

Dr. Robert Branca, DDS listed as Top Dentist in Cosmetic, Family & Implant Dentistry

Dr. Robert Branca Selected as Top Dentist in Cosmetic, Family & Implant Dentistry”

— TodaysBestDentists.com

LAKE GROVE, NEW YORK , UNITED STATES, March 27, 2017 /EINPresswire.com/ — Lake Grove, New York dentist, Dr. Robert Branca has been selected to the "America's Best Dentists" registry for 2017. Selections were made by the National Consumer Advisory Board, an organization that identifies top professionals in their fields.

Dr. Branca practices Cosmetic, Family & Implant Dentistry at Sweetwater Dental Care, 112 Alexander Avenue, Suite A in Lake Grove, serving patients in Hauppauge, Smithtown, Lake Grove, Nesconset, St James, Stonybrook and Setauket.

Services include: Bonding, White fillings, Crowns, Bridges, Teeth Whitening, Hygiene/Periodontal Health, Veneers, Dental Implants, Dentures/Partial Dentures, Extractions, Root Canal/Endodontics, Inlays/Onlays and Crown Lengthening procedures.

Dr. Branca received his Doctor of Dental Surgery degree (DDS) from Georgetown University. He is an active member of the Suffolk County Dental Society and the American Dental Association. His entire team is dedicated to educating their patients and answering all their questions in order to develop the ideal doctor-patient relationship. During his 30 years in practice he has helped thousands of patients keep their teeth and gums healthy for life.

For more information, please go to www.TodaysBestDentists.com or contact Dr. Robert Branca, DDS directly at 631-265-6655 or robertbrancadds.com.

The "National Consumer Advisory Board" accepts no fees, sponsorships, donations or advertising in their selection process. Dentists were chosen following an application based on training, experience, continuing education, and dedication to excellence. Only Dentists that satisfy all of the board's criteria can qualify for inclusion in the "Americas Best Dentists" directory.

TodaysBestDentists.com
Americas Best Dentists
5555555555
email us here


Source: EIN Presswire

TowerJazz Announces New Foundry Silicon Photonic (SiPho) Process Targeting Optical Transceiver Electronics Market

Collaborates with PhoeniX Software to provide customers with photonic PDKs for the manufacture of optical integrated circuits for optical networking components

LOS ANGELES, CALIFORNIA , USA, March 28, 2017 /EINPresswire.com/ — TowerJazz, the global specialty foundry leader,announced today a new silicon photonic process (SiPho) which complements its SiGe BiCMOS processes utilized for the manufacture of optical transceiver electronics. Further, TowerJazz is collaborating with PhoeniX Software to provide process design kits (PDKs) for its customers who are developing optical networking and data center interconnects applications. Silicon
photonics holds the potential to become a cost-effective, scalable technology for the production of photonic integrated circuits and addresses the high-performance requirements of these applications.

TowerJazz’s foundry SiPho process offering is built to enable a wide range of optical fiber
interconnect Tx and Rx front-end optical ICs. The process includes several versions of singlemode silicon waveguides, high speed germanium photodetectors, p-n junction modulators and enablement for edge and grating couplers.

PhoeniX Software’s award winning PIC design solution, OptoDesigner 5.1, uses a unique process known as photonic synthesis to map design intent into a design-rule clean circuit layout targeted to the TowerJazz SiPho process. Designers can use OptoDesigner’s parametric object oriented scripting environment and its integrated photonic simulators to optimize their designs to achieve an optimal layout that meets their performance and design requirements while also ensuring robust design manufacturability.

“We are excited to be entering the silicon photonics foundry space in order to provide solutions to a greater portion of the optical transceiver market for our customers,” said Dr. Marco Racanelli, Sr. Vice President and General Manager of RF & High Performance Analog Business Unit, TowerJazz. “As a pure-play foundry, design enablement plays a critical and complementary role to the manufacturing process and we are excited to have partnered with PhoeniX Software which has extensive experience in the silicon photonics space to bring highvalue PDKs to our customers.”

PDK-based design is key to achieving greater designer productivity and we are very excited to be working with TowerJazz to make their SiGe BiCMOS PDKs available to the Datacom market”, said Twan Korthorst, CEO of PhoeniX Software. “We are especially pleased to be working with TowerJazz as they offer world-class production capabilities to our mutual customers in the integrated photonics market.”

Availability
SiPho PDKs for TowerJazz’ SiPho process will be available Q3 2017. Please contact
info@towerjazz.com more information.

About TowerJazz

Tower Semiconductor Ltd. (NASDAQ: TSEM, TASE: TSEM) and its fully owned U.S. subsidiaries Jazz Semiconductor, Inc. and TowerJazz Texas Inc., operate collectively under the brand name TowerJazz, the global specialty foundry leader. TowerJazz manufactures integrated circuits, offering a broad range of customizable process technologies including: SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, integrated power management (BCD and 700V), and MEMS. TowerJazz also provides a world-class design enablement platform for a quick and accurate design cycle as well as Transfer Optimization and development Process Services (TOPS) to IDMs and fabless companies that need to expand capacity.

To provide multi-fab sourcing and extended capacity for its customers, TowerJazz operates two manufacturing facilities in Israel (150mm and 200mm), two in the U.S. (200mm) and three additional facilities in Japan (two 200mm and one 300mm) through TowerJazz Panasonic Semiconductor Co. (TPSCo), established with Panasonic Corporation of which TowerJazz has the majority holding. Through TPSCo, TowerJazz provides leading edge 45nm CMOS, 65nm RF CMOS and 65nm 1.12um pixel technologies, including the most advanced image sensor technologies. For more information, please visit www.towerjazz.com and www.tpsemico.com.

About PhoeniX Software

Pioneering photonics design automation already since 1991, today PhoeniX Software has a global presence and is a trusted and well recognized partner for a large number of organizations. PhoeniX Software enables the easy and cost-effective realization of integrated photonics chips and systems, by means of internally developed superior products and services. Customers range from large OEM’s to start-ups and include some of the world’s top universities and research institutes. As the leader in Photonic IC design solutions, PhoeniX Software will continue to support the transition of PIC technology from the lab into the fab, by anticipating market demand and customer needs. In combination with strategic partners, this results in offering world class design flows and access to all relevant fabrication technologies for our customers. For further information, please visit us at http://www.phoenixbv.com.

Robert van der Veer
PhoeniX Software
+31 053 483 64 60
email us here


Source: EIN Presswire

UK Biobank Partners With Big Pharma on New Treatment Solutions and Present a Keynote Address at BioBanking 2017


7th Annual BioBanking Conference

7th Annual BioBanking Conference

Generating high quality biological samples for high quality research with the UK BioBank/UK Biocentre

Biobanking 2017 – A focus on ethics and biosample management”

— SMI Group

LONDON, ENGLAND, UNITED KINGDOM, March 28, 2017 /EINPresswire.com/ — In recent news it has been announced that GSK and Regeneron are to band together in a five year study with the UK Biobank to analyse health and genetic data of middle-aged and elderly British citizens in order to shed new light on the discovery of new treatment solutions. The samples held by the UK Biobank, were originally collected between 2006 and 2010 from volunteers aged between 40 and 69.

As time passes and these volunteers increasingly develop ailments such as dementia and cancer, the database grows in utility, as these conditions can then be cross-checked against the stored genes.* Source: http://www.pharmafile.com/news/513642/gsk-and-regeneron-partner-biobank-analyse-500000-genetic-profiles

Hear more on generating high quality biological samples for high quality research when Dr Kris Spreckley, Business Development Director from the UK Biobank / UK Biocentre, presents at SMi’s 7th annual BioBanking conference when it returns to Central London on 14th and 15th June.

The in-depth talk will delve deeper into core issues surrounding:

• Sample linkage between patient and data, logistics to maintain sample integrity during transportation
• The importance of sample and data tracking during process tasks
• Sample storage for accurate tractability during storage and retrieval
• LIMS – a fundamental prerequisite for successful sample and tractability

The notable speaker line-up will also include:

• The European Commission on the impact of the General Data Protection Regulation (GDPR)
• The European Sperm Bank on ethical and regulatory considerations in sperm banking
• The Baby Biobank on co-ordinating a multi-task biobank, recruiting and dealing with large data samples
• A spotlight on digital biobanks presented by Auria Biobank and Bayer AG
• MHRA-NIBSC on progressing research in poverty related diseases

Further information including a detailed agenda and full speaker line-up is available at www.bio.banking-event.com. For those looking to attend, there is currently a £300 discount available online which expires on 31st March

BioBanking 2017
7th annual conference: 14th & 15th June | Pre-conference interactive workshop: 13th June
Holiday Inn Kensington Forum, London UK

Sponsored by Liconic UK Ltd, Scientist.com, Thermo Fisher Scientific
— end —

Contact Information:

For media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For exhibition and sponsorship enquires contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
For all other enquires contact the team on Tel: +44 (0)20 7827 6000 or email events@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group
2078276000
email us here


Source: EIN Presswire

QPS Hepatic Biosciences & PhoenixSongs Biologicals, Inc. Launch Novel Human / Human™ Hepatic Co-Culture Model

RESEARCH TRIANGLE PARK, N.C. – March 28, 2017 – QPS & PhoenixSongs Biologicals announced the release of their Human / Human ™ Hepatic Model.

RESEARCH TRIANGLE PARK, NC, USA, March 28, 2017 /EINPresswire.com/ — QPS Hepatic Biosciences & PhoenixSongs Biologicals, Inc. Launch Novel Human / Human™ Hepatic Co-Culture Model (patent pending)

RESEARCH TRIANGLE PARK, N.C. – March 28, 2017 – QPS Holdings, LLC, a contract research organization (CRO) and cell products supplier with headquarters in Newark, Delaware, and operations in the Research Triangle Park, North Carolina, and PhoenixSongs Biologicals, Inc. of Branford, Connecticut, today announced the release of their new co-developed Human / Human ™ Hepatic & Stromal Co-Culture Model.

ABOUT HUMAN / HUMAN ™
For many years, researchers in ADME, toxicology, virology, and cell biology have struggled to identify and obtain cryopreserved human hepatocytes that can be cultured for an extended period (>5 days) and maintain expression of major metabolic and drug transporter pathways as the need for more extensive characterization of hepatic interactions and secondary metabolism evaluation have also increased. The Human / Human™ model represents a fully human-derived system that is well characterized and suited for long-term culture (>30 days), while maintaining cytochrome P450, phase II, and drug transporter gene expression over the course of 5 to 30 days minimally. The supporting temporal activity data of this model demonstrates the utility of the Human / Human™ system for a variety of applications. QPS and PhoenixSongs are jointly offering pre-cultured Human / Human ™ plates to researchers (assay ready) as well as cryopreserved kits and training to allow end users to co-culture in their own laboratories. QPS and PhoenixSongs are positioned and committed to offer the Human / Human ™ model (including media) at a cost that is much less than any co-culture model on the market—essentially at a cost comparable to traditional cryopreserved hepatocytes. This Human / Human™ model is patent pending.

QUOTES
“Our research staff, technical support team and business development are extremely excited about the Human / Human ™ model and its potential impact and implications to preclinical research. Our hope, with continual collaboration and partnerships, is that our new system can help better predict clinical outcomes and potential safety risks of new chemical entities in discovery and development,” said Shiloh Barfield, a co-inventor and the Vice President of Technical Sales at QPS Hepatic Biosciences.

“Together, we have worked extremely hard to develop a model with more physiological relevance and more reproducibility than traditional in vitro liver systems and together with QPS, we are in a very unique position to offer the Human / Human™ to our partners at a price everyone should be pleased with,” said Richard Malavarca, President of PhoenixSongs Biologicals, Inc.

ABOUT QPS HOLDINGS, LLC
Founded in 1995, QPS is a minority-owned business enterprise (MBE) and a GLP/GCP-compliant CRO supporting discovery, preclinical, and clinical drug development. QPS provides quality services to pharmaceutical, chemical, biotechnology, and academic groups, as well as research centers, worldwide. The linearly integrated core competencies include: DMPK, toxicology, bioanalysis, translational medicine, early stage clinical research, and Phase 2 – 4 clinical research. Regional laboratories and testing facilities are located at QPS headquarters in Newark, DE, USA; Springfield, MO, USA; Research Triangle Park, NC, USA; South Miami, FL, USA; Groningen, The Netherlands; Graz, Austria; Hyderabad, India; and Taipei, Taiwan. For more information, visit http://www.qps.com.

ABOUT PHOENIXSONGS BIOLOGICALS, INC.
PhoenixSongs Biologicals, Inc. was founded by Dr. Lola M. Reid, Marsha Roach (stem cell research and cellular model development) and Richard Malavarca (media formulation, development, and production) who all have vast experience developing cellular models in the pharmaceutical industry covering all phases of the drug discovery, development, and research process. More specifically, the founders have expertise in developing pre-clinical cellular model systems with human, bovine, porcine and rodent embryonic stem cells, iPS cells, neural stem cells and neuronal model systems, hepatic stem cells, and biliary tree stem cells. They also have expertise in custom media and maturational lineages of human and rodent livers, and biliary tree and pancreas, and in using hormonally defined media and extracellular matrix conditions for these cells. Their collective expertise enables PhoenixSongs Biologicals to establish stem cells or differentiated cell derivatives under wholly defined conditions as models for use in academic and industrial investigations. For more information, visit www.phoenixsongsbio.com.

MEDIA CONTACT:
Shiloh J. Barfield
VP of Technical Sales
QPS Hepatic Biosciences
919-699-0033
Shiloh.barfield@qps.com

Shiloh Barfield
QPS Hepatic Biosciences
919-699-0033
email us here


Source: EIN Presswire

Manny Schecter of IBM is Named to Board of Directors of The Center for Intellectual Property Understanding

IBM's Chief Patent Counsel is an active proponent of IP education.

NEW YORK, NY, UNITED STATES, March 28, 2017 /EINPresswire.com/ — New York, NY, March 28, 2017 – The Center for Intellectual Property Understanding, a non-profit devoted to increasing awareness of IP rights and their impact on peoples’ lives, announced today that Manny W. Schecter, Chief Patent Counsel of IBM Corporation, has joined the board of directors.

“I am delighted to have the opportunity to serve on the board of the Center for IP Understanding,” said Mr. Schecter. “The Center’s timely mission, to increase awareness and improve attitudes towards patents and other IP rights, serves the general public and advances a much-needed IP education initiative.”

Mr. Schecter joins other CIPU directors, Marshall Phelps (retired head of IP Business and Strategy at Microsoft and IBM), Brian Hinman (Chief IP Officer at Philips), Keith Bergelt (Open Invention Network CEO) and Harry Gwinnell (former head of IP at Cargill and founding President of the IPO Education Foundation).

About the Center for IP Understanding

The Center for Intellectual Property Understanding is an independent, non-profit organization dedicated to increasing awareness of intellectual property rights and their impact on people’s lives. CIPU conducts research, provides information and facilitates education that seek to improve the reputation of IP rights and deter infringement. The Center also tracks attitudes toward IP rights, including patents, copyrights and trademarks, and through outreach provides a framework for the facilitation of ideas, promotion of competition and creation of jobs. CIPU is granted tax-exempt status by the IRS as a 501(c)(3). For more information, please visit our website (www.UnderstandingIP.org) or Twitter or Facebook.

Bruce Berman
Center for IP Understanding
2125089664
email us here


Source: EIN Presswire